PROCEPT BioRobotics Corporation
HealthcareNASDAQ:PRCT · NASDAQ Global Market
-$1.99 today
Vol 1.38M · Avg 1.37M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $245.6M |
| Receivables | $96.4M |
| Inventory | $77.5M |
| Other Current | $8.5M |
| Total Current Assets | $428.0M |
| PP&E (Net) | $48.9M |
| Intangible Assets | $640.0K |
| Other Non-current | $9.5M |
| Total Non-current Assets | $59.0M |
| Total Assets | $487.1M |
Analysis
Selected assets total $487.1M for Latest. The largest visible component is Cash & Equivalents at $245.6M, about 50.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $286.5M -14.1% | $333.7M +29.7% | $257.2M +15.5% | $222.6M -26.8% | $304.3M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $83.5M +0.0% | $83.5M +72.6% | $48.4M +216.8% | $15.3M +242.1% | $4.5M | $533.8M | $399.4M | -$1.7B |
| Inventory | $70.7M +25.9% | $56.2M +41.3% | $39.8M +39.3% | $28.5M +117.1% | $13.1M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $9.6M +14.1% | $8.5M +62.2% | $5.2M -15.6% | $6.2M +81.0% | $3.4M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $450.4M -6.5% | $481.8M +37.4% | $350.6M +28.6% | $272.6M -16.4% | $326.2M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $47.9M +5.0% | $45.6M -6.8% | $49.0M +52.4% | $32.1M +286.1% | $8.3M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $709.0K -23.9% | $932.0K -22.6% | $1.2M -18.5% | $1.5M -15.6% | $1.8M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $0 -100.0% | $3.0M +0.0% | $3.0M +0.0% | $3.0M +291.0% | $777.0K | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $9.1M +254.5% | $2.6M +178.0% | $919.0K +1702.0% | $51.0K | $0 | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $57.7M +10.6% | $52.2M -3.6% | $54.1M +47.5% | $36.7M +238.2% | $10.9M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $508.1M -4.9% | $534.0M +31.9% | $404.7M +30.8% | $309.3M -8.2% | $337.0M | $13.3B | $11.9B | $10.6B |
| Account Payables | $17.3M +72.3% | $10.0M -25.7% | $13.5M +43.7% | $9.4M +362.8% | $2.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $0 -100.0% | $1.9M +13.5% | $1.7M -20.9% | $2.1M +1.1% | $2.1M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $2.1M +19.9% | $1.7M +108.1% | $829.0K +61.0% | $515.0K | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $13.0M +36.4% | $9.6M +69.1% | $5.7M +98.1% | $2.9M +178.5% | $1.0M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $35.5M +251.5% | $10.1M +23.0% | $8.2M +9.9% | $7.5M +62.1% | $4.6M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $65.8M +23.8% | $53.1M +15.7% | $45.9M +30.1% | $35.3M +117.3% | $16.2M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $51.6M +0.3% | $51.5M +0.3% | $51.3M +0.2% | $51.2M +2.4% | $50.0M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $24.8M +7554.6% | $324.0K -37.3% | $517.0K -70.9% | $1.8M +4.9% | $1.7M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $76.4M -2.9% | $78.7M +0.8% | $78.0M +1.4% | $77.0M +43.4% | $53.7M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $142.2M +7.9% | $131.8M +6.3% | $124.0M +10.4% | $112.3M +60.5% | $69.9M | $14.7B | $3.7B | $9.6B |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$641.6M -17.5% | -$546.0M -20.1% | -$454.6M -30.4% | -$348.7M -33.3% | -$261.5M | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $0 -100.0% | $114.0K +35.7% | $84.0K +1500.0% | -$6.0K +88.9% | -$54.0K | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $1.0B | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $365.9M -9.0% | $402.2M +43.3% | $280.8M +42.5% | $197.1M -26.2% | $267.1M | $9.1B | $7.7B | $3.3B |
| Total Debt | $51.6M -35.7% | $80.3M +1.3% | $79.2M +2.4% | $77.3M +42.9% | $54.1M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$234.9M +7.3% | -$253.5M -42.4% | -$178.0M -22.5% | -$145.3M +41.9% | -$250.2M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Twist Bioscience Corporation
NASDAQ:TWST
$4.74B
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
$3.75B
Guardian Pharmacy Services, Inc.
NYSE:GRDN
$2.73B
Clover Health Investments, Corp.
NASDAQ:CLOV
$2.45B
Mesoblast Limited
NASDAQ:MESO
$1.79B
Inspire Medical Systems, Inc.
NYSE:INSP
$1.23B
Artivion, Inc.
NYSE:AORT
$975.72M
QuidelOrtho Corporation
NASDAQ:QDEL
$963.54M
SS Innovations International, Inc.
NASDAQ:SSII
$672.44M
BGM Group Ltd.
NASDAQ:BGM
$75.23M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does PRCT have?
PROCEPT BioRobotics Corporation (PRCT) reported $286.50M in cash and equivalents in fiscal 2025.
How much debt does PRCT carry?
PROCEPT BioRobotics Corporation (PRCT) reported $51.62M of total debt, with net debt of -$234,888,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.